Evidence map›Paper›PMID 15161743›Full record

ArticleDiabetes2004

Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo.

Michelle A Vincent, Lucy H Clerk, Jonathan R Lindner, Alexander L Klibanov, Michael G Clark, Stephen Rattigan, Eugene J Barrett

5 registry-linked trialsOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetes, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 194 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
194citing papers in PubMed, 1 pooled it
52.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03883412 phase4recruitingstarted 2019, after this paper: background citation

Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)

Ran2019Enrolled60Registered outcomes6Posted comparisons0ConditionsType2 DiabetesArmsExercise, liraglutide
Open the trial in the graph
NCT04575844 phase4recruitingstarted 2020, after this paper: background citation

Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome

Ran2020Enrolled80Registered outcomes6Posted comparisons0ConditionsMetabolic SyndromeArmsExercise Training, liraglutide, Liraglutide + Exercise training
Open the trial in the graph
NCT05478707 phase2recruitingstarted 2023, after this paper: background citation

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

Ran2023Enrolled47Registered outcomes5Posted comparisons0ConditionsDiabetes Mellitus, Type 1, Endothelial DysfunctionArmsDulaglutide, Placebo
Open the trial in the graph
NCT02490124 completednot on this mapstarted 2014, after this paper: background citation

The Effect of Type 1 Diabetes on Pan-Arterial Vascular Function and Insulin Sensitivity in Humans

TypeobservationalSponsorUniversity of VirginiaRan2014 to 2015Enrolled7ConditionsDiabetes Type 1
NCT03174288 nacompletednot on this mapstarted 2015, after this paper: background citation

The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes

TypeinterventionalSponsorUniversity of VirginiaRan2015 to 2019Enrolled32ConditionsType 1 DiabetesArmsExercise, Spironolactone
3 · Its place in the literature

Who cites it

194 citing papers in PubMed, 1 synthesis or guideline pooled it, 433 citations in OpenAlex.

  1. Utility of Contrast-Enhanced Ultrasound for the Assessment of Skeletal Muscle Perfusion in Diabetes Mellitus: A Meta-Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Pooled it
  2. Beneficial vascular effects of oral phosphatidylserine supplementation in type 2 diabetes.Journal of applied physiology (Bethesda, Md. : 1985) · 2026
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Differential effects of nebivolol vs. metoprolol on microvascular function in hypertensive humans.American journal of physiology. Heart and circulatory physiology · 2016
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans.The Journal of clinical endocrinology and metabolism · 2011 · on this map
    Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

134 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Michelle A VincentDepartment of Internal Medicine, Box 801410, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA.
Lucy H Clerk
Jonathan R Lindner
Alexander L Klibanov
Michael G Clark
Stephen Rattigan
Eugene J Barrett
University of Virginia · USUniversity of Tasmania · AU

Funding

REGULATION OF SKELETAL MUSCLE PROTEIN METABOLISM IN MANR01DK038578 · NIDDK · YALE UNIVERSITY · PI BARRETT, EUGENE J · 1987 to 2004
$1.2M
MICROVASCULAR ENDOTHELIAL FUNCTION WITH MICROBUBBLESK08HL003810 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LINDNER, JONATHAN R · 1998 to 2002
$331k
IN VIVO ACTIONS OF IGF 1 ON HUMAN MUSCLE METABOLISMR01DK054058 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI FRYBURG, DAVID A · 1997 to 2000
$163k
NHLBI NIH HHS K08 HL-03810NIDDK NIH HHS DK-38578NIDDK NIH HHS DK-54058
6 · The paper itself

Abstract

Insulin increases glucose disposal into muscle. In addition, in vivo insulin elicits distinct nitric oxide synthase-dependent vascular responses to increase total skeletal muscle blood flow and to recruit muscle capillaries (by relaxing resistance and terminal arterioles, respectively). In the current study, we compared the temporal sequence of vascular and metabolic responses to a 30-min physiological infusion of insulin (3 mU. min(-1). kg(-1), euglycemic clamp) or saline in rat skeletal muscle in vivo. We used contrast-enhanced ultrasound to continuously quantify microvascular volume. Insulin recruited microvasculature within 5-10 min (P < 0.05), and this preceded both activation of insulin-signaling pathways and increases in glucose disposal in muscle, as well as changes in total leg blood flow. Moreover, l-NAME (N(omega)-nitro-l-arginine-methyl ester), a specific inhibitor of nitric oxide synthase, blocked this early microvascular recruitment (P < 0.05) and at least partially inhibited early increases in muscle glucose uptake (P < 0.05). We conclude that insulin rapidly recruits skeletal muscle capillaries in vivo by a nitric oxide-dependent action, and the increase in capillary recruitment may contribute to the subsequent glucose uptake.

Indexed as

AnimalsBlood VesselsContrast MediaEnzyme InhibitorsGlucoseInsulinMaleMicrocirculationMicrospheresMuscle, SkeletalNG-Nitroarginine Methyl EsterRatsRats, Sprague-DawleyUltrasonographyContrast MediaEnzyme InhibitorsGlucoseInsulinNG-Nitroarginine Methyl Ester

Identifiers

PMID15161743
OpenAlexW2010102296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.